GI Endoscopy · 1 min read
ACLF: Diagnosis and Multi-Organ Management (2026)
Clinical Bottom Line
| Precipitating Event | Systemic Pathophysiology | ICU Management Goal |
|---|---|---|
| Bacterial Infection (SBP) | Massive systemic inflammatory response (SIRS) and cytokine storm. | STAT broad-spectrum antibiotics and aggressive intravenous albumin. |
| Active Alcohol Abuse | Acute alcoholic hepatitis superimposed on severe cirrhosis. | Steroid therapy (Maddrey's >32) if no active infection; nutritional support. |
| Variceal Hemorrhage | Hemorrhagic shock inducing profound splanchnic ischemia. | Emergent endoscopic banding, vasoactive drips, and prophylactic antibiotics. |
Defining Acute-on-Chronic Liver Failure (ACLF)
ACLF is a distinct, devastating clinical syndrome characterized by the acute decompensation of chronic liver disease (cirrhosis) accompanied rapidly by the failure of secondary extrapulmonary organs (kidneys, brain, cardiovascular system). Unlike a simple ascites decompensation, ACLF carries a grim 28-day mortality rate often exceeding 30-50%.
The Crucial Role of Inflammation
The cardinal driver of ACLF is not merely hepatocyte necrosis, but intense systemic inflammation driven by pathogen-associated molecular patterns (PAMPs) translocating across a highly permeable, portally hypertensive gut. This systemic burst of inflammation causes rapid vasodilation and circulatory dysfunction, primarily plummeting the patient into hepatorenal syndrome (HRS-AKI) and advanced hepatic encephalopathy. Resuscitation requires immediate ICU admission, organ support, and evaluating eligibility for expedited liver transplantation.
Clinical guidelines summarized by the Gastroscholar Research Team. Last updated: 2026. This article is intended for physicians.
For your teaching file
Save this article as a PDF
Drop your email and we'll open a print-ready version you can save as a PDF — and you'll start getting our weekly GI endoscopy newsletter.